Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
A tool called “polygenic risk scoring” could help physicians identify who faces a high risk of serious diseases.
A Yale University team found two potential methods for preventing fat particles from slipping into tissues.
Insmed aims to bring a first-in-market therapy to patients in the U.S. suffering from NTM lung disease caused by MAC, a chronic and debilitating condition.
PARP inhibitors prevent the misplacement of a specific protein that has been implicated in ALS, new research shows.
Norovirus and rotavirus get transmitted to humans through "virus clusters" that exacerbate the spread of the illnesses.
Researchers have discovered seven gene alterations that could improve surveillance for triple-negative breast cancer risk.
Suppressing the YAP protein, known for its role in modulating cell death, may help free up the immune system to fight cancer.
Replacing the enzyme used in CRISPR gene editing may alleviate safety concerns, new research suggests.
A rare cell type, discovered by two teams and named as "pulmonary ionocyte," appears to help drive cystic fibrosis.
The past week’s biotech news included insight into how ApoE4 raises Alzheimer’s risk and a peptide vaccine for broad flu protection.
Blocking the signaling receptor NLRP3 could treat a range of autoimmune disorders, IFM researchers believe.